Evidence map›Paper›PMID 21773979›Full record

ReviewBioEssays : news and reviews in molecular, cellular and developmental biology2011

The secreted kinase ROP18 defends Toxoplasma's border.

Sarah J Fentress, L David Sibley

Abstract readReview
In one paragraph

Review in BioEssays : news and reviews in molecular, cellular and developmental biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Therapeutic Antitoxoplasmosis Potential ofJournal of tropical medicine · 2026
    Article
  2. Review
  3. Review
  4. To kill a tachyzoite: assault and battery.Trends in parasitology · 2024
    Article
  5. The luminal domain ofFrontiers in parasitology · 2023
    Article
  6. Review
  7. Released Parasite-Derived Kinases as Novel Targets for Antiparasitic Therapies.Frontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sarah J FentressDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
L David Sibley
Washington University in St. Louis · US

Funding

MOLECULAR BASIS OF TOXOPLASMOSIS IN AIDS PATIENTSR01AI036629 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 1994 to 2013
$5.3M
TARGETING ESSENTIAL ROP KINASES IN TOXOPLASMAR01AI082423 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 2009 to 2015
$2.9M
Discovery of novel antibacterials from a mushroom natural product libraryR43AI084243 · NIAID · LIFEPHARMS, INC. · PI MENA, ESTEBAN EDWARD · 2009 to 2009
$378k
NIAID NIH HHS AI036629NIAID NIH HHS AI084243NIAID NIH HHS R01 AI036629NIAID NIH HHS R01 AI082423NIAID NIH HHS R43 AI084243
6 · The paper itself

Abstract

Toxoplasma gondii is a highly successful parasite capable of infecting virtually all warm-blooded animals by actively invading nucleated host cells and forming a modified compartment where it replicates within the cytosol. The parasite-containing vacuole provides a safe haven, even in professional phagocytes such as macrophages, which normally destroy foreign microbes. In an effort to eliminate the parasite, the host up-regulates a family of immunity-related p47 GTPases (IRGs), which are recruited to the parasite-containing vacuole, resulting in membrane rupture and digestion of the parasite. To avoid this fate, highly virulent strains of Toxoplasma coat the external surface of their vacuole with a secretory serine/threonine kinase, known as ROP18. At this host-pathogen interface, ROP18 phosphorylates and inactivates IRGs, thereby protecting the parasite from killing. These findings reveal a novel molecular mechanism by which the parasite disarms host innate immunity.

Indexed as

Immunity, InnateAnimalsGTP PhosphohydrolasesHost-Parasite InteractionsHumansMembrane ProteinsPhylogenyProtein Serine-Threonine KinasesProtozoan ProteinsToxoplasmaToxoplasmosisVacuolesGTP PhosphohydrolasesMembrane ProteinsProtein Serine-Threonine KinasesProtozoan ProteinsROP18 protein, Toxoplasma gondiiROP 2 protein, Toxoplasma gondii

Identifiers

PMID21773979
PMCPMC3378050
OpenAlexW1991605806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.